NCATS Announces the Cures Acceleration Network Review Board Workshop: Repurposing Off-Patent Drugs: Research & Regulatory Challenges

Notice Number: NOT-TR-19-029

Key Dates
Release Date: October 7, 2019

Related Announcements
None

Issued by
National Center for Advancing Translational Sciences (NCATS)

Purpose

Workshop Details

Cures Acceleration Network Review Board Workshop

Repurposing Off-Patent Drugs: Research & Regulatory Challenges

December 5-6, 2019

Hilton Rockville Hotel & Executive Meeting Center, 1750 Rockville Pike, Rockville, MD

Register to Attend: https://reaganudall.salsalabs.org/repurposingoffpatentdrugsworkshop/index.html

NCATS is hosting the Cures Acceleration Network Review Board Workshop:

Repurposing Off-Patent Drugs: Research & Regulatory Challenges on December 5-6, 2019. The workshop will assess challenges around finding new uses for drugs that are already on the market but lack commercial and regulatory incentives for research and development. On December 5 we will map out the challenges to repurposing off-patent drugs. On December 6, we will host interactive work sessions focused on capturing possible solutions.

The target audience includes patients, philanthropists, non-governmental organizations, academics, pharmaceutical developers, manufacturers, health economists, patent/intellectual property lawyers, regulatory policy experts, computational scientists, payors, and funders.

Background

The Cures Acceleration Network Review Board (CAN RB) advises and provides recommendations to the NCATS Director with respect to significant barriers to successful translation of basic science into clinical application. In support of this mandate, the CAN RB will co-host this public workshop to discuss challenges around finding new uses for drugs that are already on the market but lack commercial and regulatory incentives for research and development.

The workshop is being co-sponsored by the NCATS Cures Acceleration Network Review Board, NCATS Drug Development Partnership Programs, Food and Drug Administration, and Reagan-Udall Foundation for the FDA.

Register Online

The workshop is free and open to the public. Registration is required, and attendees can register by December 2, 2019, 5:00 p.m. EST. Early registration is recommended because seating is limited.

More Information

For more information, visit: https://reaganudall.salsalabs.org/repurposingoffpatentdrugsworkshop/index.html

Inquiries

Please direct all inquiries to:

Bobbie Ann Mount, Ph.D.
National Center for Advancing Translational Sciences (NCATS)
Telephone: 301-435-0824
Email: NewTherapeuticUses@mail.nih.gov